human mAbs (Merus)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehuman mAbs (Merus)
Drug Alias NameRTK modulators (Merus)receptor tyrosine kinase modulators (Merus)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionReceptor protein-tyrosine kinase modulators
TargetsReceptor protein-tyrosine kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerus Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerus Nv
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A